Saturday, August 23, 2025

Latest

Therma Bright Ends Arrangement With Torian Biosciences, Assumes 100% Control Of Saliva Rapid Test

Therma Bright (TSXV: THRM) has taken back control of the research and development, regulatory, manufacturing and commercialization of its saliva-based COVID-19 rapid antigen test. The move enables the company to retain all potential future revenues from the sale of the test, if it achieves that point in its development.

The company had previously entered into an agreement on November 4, whereby Torian Biosciences was to be responsible for developing, licensing and commercializing the rapid test. The arrangement was to see the company own a 50% stake in the venture, while the other half was to be controlled by others.

At the time, the move resulted in the company terminating its co-development arrangement with Orpheus Medica.

It appears however that that arrangement has already fallen apart, with Therma Bright now retaining 100% control of the saliva test yet again, while also moving to rename the product from CoviSafe to SCV2. The new name is reportedly temporary until a new name can be established.

The company is now in the process of advancing discussions with testing sites in Canada, the UK and the United States. The company is also reportedly in the process of identifying component suppliers for large scale manufacturing of the test, while also looking to identify contract manufacturers for final assembly of the product.

Therma Bright last traded at $0.485 on the TSX Venture.


Information for this briefing was found via Sedar and Therma Bright Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Aya Gold Q2 Earnings: Production Slips Amid Ramp Up

i-80 Gold Q2 Earnings: Better, But Not Great

Artemis Q2 Earnings: Strong Start For A New Operator

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Therma Bright Improves COVID-19 Rapid Saliva Antigen Test To 86% Sensitivity, 100% Specificity

Therma Bright Inc (TSXV: THRM) this afternoon halted its equity from trading for the dying...

Monday, January 18, 2021, 04:22:30 PM

Therma Bright Expects Rapid Antigen Saliva Test Study To Conclude This Month

Therma Bright (TSXV: THRM) this morning provided a brief update to investors on the status...

Thursday, January 20, 2022, 08:59:08 AM

Therma Bright Development Partner Discovers Detection Molecule For COVID-19 Test

Therma Bright Inc (TSXV: THRM) this morning announced that its development partner for its COVID-19...

Thursday, September 3, 2020, 09:39:35 AM